Metformin and Long COVID, Central Lines and Thrombocytopenia, DOACs vs LMWH in Cancer Associated Thrombosis, Early vs Late Anticoagulation after Stroke with Atrial Fibrillation
Last Week in Medicine
00:00
Introduction
A discussion on the findings of the COVID out trial, which investigated the use of metformin, fluvoxamine, and ivermectin as outpatient therapeutics for COVID-19, and the benefits of metformin in reducing ED visits, hospitalizations, and deaths when started early.
Play episode from 00:00
Transcript
